💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
All Recalls
92,900 total recalls in our database
💊 Drugs Class I - Dangerous
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
💊 Drugs Class I - Dangerous
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
💊 Drugs Class I - Dangerous
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
💊 Drugs Class I - Dangerous
Lack of Assurance of Sterility
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
💊 Drugs Class I - Dangerous
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000 g container (NDC: 58597-8023-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327
American Pharmaceutical Ingredients
💊 Drugs Class I - Dangerous
CGMP Deviations: Lack of quality assurance at the API manufacturer.
💊 Drugs Class I - Dangerous
GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.
Chlorhexidine Gluconate 0.12% Oral Rinse, USP, 1 Pint (473 ml), Rx Only, Distributed by: Xttrium Laboratories, Inc., Mount Prospect, IL 60056, NDC 0116-2001-16
Xttrium Laboratories
💊 Drugs Class I - Dangerous
CGMP Deviations
Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405
Fagron Compounding Services LLC
💊 Drugs Class I - Dangerous
Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier
💊 Drugs Class I - Dangerous
Cross Contamination With Other Product: Imipramine
💊 Drugs Class I - Dangerous
Lack of Assurance of Sterility
💊 Drugs Class I - Dangerous
Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.
Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01
Lantheus MI Radipharmaceuticals
💊 Drugs Class I - Dangerous
Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Lot and/or Exp Date